Related Experiment Videos
[Euconol in the treatment of patients with ischemic heart disease]
Insights
Euconol, a foodstuff, demonstrated significant antianginal effects in patients with coronary heart disease. Long-term intake improved lipid profiles and reduced episodes of chest pain and silent ischemia.
Area of Science:
- Cardiology
- Nutritional Science
- Pharmacology
Context:
- Investigated the clinical efficacy of "euconol", a dietary supplement, in managing cardiovascular conditions.
- Focused on patients diagnosed with coronary heart disease (CHD), stable angina, postinfarct cardiosclerosis, and silent myocardial ischemia.
Purpose:
- To evaluate the antianginal and cardioprotective effects of euconol in a clinical setting.
- To assess the impact of prolonged euconol consumption on cardiovascular events and blood lipid profiles.
Summary:
- A study involving 72 patients with various coronary heart conditions assessed the efficacy of euconol.
- A significant antianginal effect was observed in 51.4% of patients receiving euconol.
- Treatment led to a marked reduction in anginal episodes, nitroglycerin use, and silent myocardial ischemia over four months.
Impact:
- Euconol intake positively influenced blood lipid composition.
- Prolonged euconol consumption demonstrated beneficial effects on the natural progression of coronary heart disease.
- Suggests potential for euconol as a complementary therapy in cardiovascular disease management.
Abstract:
The clinical efficacy of the foodstuff euconol was studied in 72 patients with coronary heart diseases, stable angina of effort, postinfarct cardiosclerosis, or silent myocardial ischemia. A good antianginal effect was achieved in 51.4% of patients treated with euconol. At month 4 of treatment, the patients with coronary heart disease displayed a significant decrease in the number of anginal episodes and nitroglycerin tablets; this was followed by a reduction in the number and duration of silent myocardial ischemic episodes. It is concluded that a prolonged euconol intake causes positive changes in the blood lipid composition and natural history of coronary heart disease.